Passage Bio, Inc. Gains 69.52%
Fri, Nov 29, 2024 at 07:30 PM
Passage Bio, Inc. (PASG:NASDAQ) shot up at $1.13, a gain of 69.5%. On Fri, Nov 29, 2024, PASG:NASDAQ touched a New 2-Week High of $1.13. The stock got featured on our News Catalysts scanner on Thu, Nov 14, 2024 at 08:00 AM in the 'MISCELLANEOUS' category. From Fri, Nov 15, 2024, the stock recorded 66.67% Up Days and 60.00% Green Days
About Passage Bio, Inc. (PASG:NASDAQ)
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.
Top 10 Gainers:
- F45 Training Holdings Inc. (FXLV:NYSE), 284.62%
- Bolt Projects Holdings Inc Com (BSLK:NASDAQ), 139.86%
- ParaZero Technologies Ltd. (PRZO:NASDAQ), 94.14%
- Unusual Machines Inc. (UMAC:NYSEMKT), 89.38%
- Thunder Power Holdings Inc Com (AIEV:NASDAQ), 87.25%
- Passage Bio, Inc. (PASG:NASDAQ), 69.52%
- Sunrise New Energy Co. Ltd Ord (EPOW:NASDAQ), 45.29%
- Primega Group Holdings Limited (PGHL:NASDAQ), 44.24%
- Trident Digital Tech Holdings Ltd (TDTH:NASDAQ), 43.24%
- AgEagle Aerial Systems, Inc. (UAVS:NYSEMKT), 42.16%